Individual participant data meta-analyses compared with meta-analyses based on aggregate data

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 9, 2016, Pages

  Tudur Smith, Catrin ^a   Marcucci, Maura ^b,c   Nolan, Sarah J ^a   Iorio, Alfonso ^b   Sudell, Maria ^a   Riley, Richard ^d   Rovers, Maroeska M ^e   Williamson, Paula R ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF MILAN   (Italy)

^d KEELE UNIVERSITY   (United Kingdom)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COCHRANE LIBRARY; CONTROLLED STUDY; ECONOMIC EVALUATION; EDITORIAL; EMBASE; FEMALE; FOLLOW UP; HUMAN; LIMIT OF AGREEMENT; MALE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

EID: 85013931595     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.MR000007.pub3     Document Type: Editorial

References (54)

1. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI, Anti-Lymphocyte Antibody Induction Therapy Study G. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Statistics in Medicine 2002;21(3):371-87. x-wiley/crsRef/4361238
2. Best L, Simmonds P, Baughan C, Buchanan R, Davis C, Fentiman I, et al. Collaboration Colorectal Meta-analysis. Palliative chemotherapy for advanced or metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD001545]x-wiley/crsRef/4361240
3. Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Internal Medicine 2015;175(5):745-54. x-wiley/crsRef/4361242
4. Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, et al. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. European Heart Journal 2009;30(7):820-6. x-wiley/crsRef/4361244
5. Clarke M, Godwin J. Systematic reviews using individual patient data: A map for the minefields?. Annals of Oncology 1998;9:827-33. x-wiley/crsRef/4361246
6. D'Amico R, Pifferi S, Leonetti, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998;316:1275–85. x-wiley/crsRef/4361248
7. Duchateau L, Pignon JP, Bijnens L, Bertin S, Bourhis J, Sylvester R. Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. Controlled Clinical Trials 2001;22(5):538-47. x-wiley/crsRef/4361250
8. Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. Journal of Clinical Epidemiology 1995;48(11):1379-90. x-wiley/crsRef/4361252
9. Franzosi MG, Santoro E, Santoro L. Prospective meta-analysis using individual patient data vs meta-analysis of published reports: the case of ACE-inhibitors in myocardial infarction. Controlled Clinical Trials 1997;18:183s. x-wiley/crsRef/4361254
10. Ioannidis JP, Contopoulos-Ioannidis DG, Lau J. Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. Journal of Clinical Epidemiology 1999;52(4):281-91. x-wiley/crsRef/4361256
11. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs individual patient data: Paternal cell immunization for recurrent miscarriage. JAMA 1995;274(10):830-6. x-wiley/crsRef/4361258
12. Jones AP, Riley RD, Williamson PR, Whitehead A. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clinical Trials 2009;6(1):16-27. x-wiley/crsRef/4361260
13. Kim PW, Wu YT, Cooper C, Rochester G, Valappil T, Wang Y, et al. Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clinical Infectious Diseases 2010;51(4):381-9. x-wiley/crsRef/4361262
14. Koopman L, van der Heijden GJ, Hoes AW, Grobbee DE, Rovers MM. Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses. International Journal of Technology Assessment in Health Care 2008;24(3):358-61. x-wiley/crsRef/4361264
15. le Chevalier T. Chemotherapy for advanced NSCLC: Will meta-analysis provide the answer?. Chest 1996;109(5 Suppl):107s-9s. x-wiley/crsRef/4361266
16. Legg L, Leonardi-Bee J, Langhorne P, Walker M. Is getting individual patient data for meta-analyses worthwhile?. XI Cochrane Colloquium: Evidence, Health Care and Culture. 2003. x-wiley/crsRef/4361268
17. Lindley RI, Wardlaw JM, Sandercock PA. Alteplase and ischaemic stroke: have new reviews of old data helped?. Lancet Neurology 2005;4(4):249-53. x-wiley/crsRef/4361270
18. Lukka H, Waldron T, Klotz L, Winquist E, Trachtenberg J. Maximal androgen blockade for the treatment of metastatic prostate cancer--a systematic review. Current Oncology (Toronto, Ont.) 2006;13(3):81-93. x-wiley/crsRef/4361272
19. Michiels S, Piedbois P, Burdett S, Syz N, Stewart L, Pignon JP. Meta-analysis when only the median survival times are known: a comparison with individual patient data results. International Journal of Technology Assessment in Health Care 2005;21(1):119-25. x-wiley/crsRef/4361274
20. Myeloma Trialists' Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Journal of Clinical Oncology 1998;16(12):3832-42. x-wiley/crsRef/4361276
21. Pignon JP, Arriagada R. Role of thoracic radiotherapy in limited-stage small-cell lung cancer: quantitative review based on the literature versus meta-analysis based on individual data. Journal of Clinical Oncology 1992;10(11):1819-20. x-wiley/crsRef/4361278
22. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. Journal of Clinical Endocrinology 2012;97(8):2670-81. x-wiley/crsRef/4361280
23. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377(9759):31-41. x-wiley/crsRef/4361282
24. Saillourglenisson F, Chene G, Salmi LR, Hafner R, Salamon R. Effect of dapsone on survival in HIV infected patients: a meta- analysis of finished trials [Effet de la dapsone sur la survie des patients infectés par le VIH: une métaanalyse des essais terminés]. Revue d'Epidemiologie et de Sante Publique 2000;48(1):17-30. x-wiley/crsRef/4361284
25. Schmid CH, Stark PC, Berlin JA, Landais P, Lau J. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. Journal of Clinical Epidemiology 2004;57(7):683-97. x-wiley/crsRef/4361286
26. Shepperd S, Doll H, Broad J, Gladman JS, Langhorne P, Richards S, et al. Hospital at home early discharge. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD000356.pub3]x-wiley/crsRef/4361288
27. Spooner C, Rowe BH, Saunders LD, Milner RA. Nedocromil sodium as treatment of exercise-induced bronchoconstriction: a comparison of results from a meta-analysis with individual patient data. 6th Cochrane Colloquium. 1998; Vol. A03. x-wiley/crsRef/4361290
28. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 1993;341(8842):418-22. x-wiley/crsRef/4361292
29. Szczech LA, Berlin JA, Feldman HI, for the Anti-Lymphocyte Antibody Induction Therapy Study Group. The effect of antilymphocyte induction therapy on renal allograft survival. Annals of Internal Medicine 1998;128:817-26. x-wiley/crsRef/4361294
30. Teramukai S, Matsuyama Y, Mizuno S, Sakamoto J. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Japanese Journal of Clinical Oncology 2004;34(12):717-21. x-wiley/crsRef/4361296
31. Thompson SG, Turner RM, Warn DE. Multilevel models for meta-analysis, and their application to absolute risk differences. Statistical Methods in Medical Research 2001;10(6):375-92. x-wiley/crsRef/4361298
32. Tierney J, Rydzewska L, Burdett S. Feasibility and reliability of using hazard ratios in meta-analyses of published time-to-event data. 9th Cochrane Colloquium. 2001; Vol. O-002. x-wiley/crsRef/4361300
33. Tonia T, Bohlius J. Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients. Cancer Treatment and Research 2011;157:217-38. x-wiley/crsRef/4361302
34. Tudur C, Williamson PR, Khan SA, Best L. The value of the aggregate data approach in meta-analysis with time-to-event outcomes. Journal of the Royal Statistical Society. Series a (General) 2001;164:357-70. x-wiley/crsRef/4361304
35. Tudur Smith C, Williamson PR, Marson AG. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. Journal of Evaluation in Clinical Practice 2005;11(5):468-78. x-wiley/crsRef/4361306
36. Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 2000;19(24):3417-32. x-wiley/crsRef/4361308
37. Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, et al. Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. Lung Cancer (Amsterdam, Netherlands) 2012;76(3):478-85. x-wiley/crsRef/4361310
38. Walwyn R, Roberts C. Meta-analysis of absolute mean differences from randomised trials with treatment-related clustering associated with care providers. Statistics in Medicine 2015;34(6):966-83. x-wiley/crsRef/4361312
39. Williamson PR, Marson AG, Tudur C, Hutton JL, Chadwick D. Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials. Journal of Evaluation in Clinical Practice 2000;6(2):205-14. x-wiley/crsRef/4361314
40. Ahmed I, Sutton AJ, Riley RD. Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ 2012;3(344):d7762.
41. Chalmers I. The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Annals of the New York Academy of Sciences 1993;703:156-65.
42. Clarke M, Stewart L. Individual patient data or published data meta-analysis: a systematic review. Proceedings of the Fifth Cochrane Collaboration Colloquium. 1997:94, abstract 019.04.
43. Cools F, Askie L, Offringa M, Asselin M, Calvert JM, Courtney SA, et al. Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data. Lancet 2010;375:2082-91.
44. Cooper H, Patall EA. The relative benefits of meta-analysis conducted with individual participant data versus aggregated data. Psychological Methods 2009;14(2):165-76.
45. Cope S, Zhang J, Williams J, Jansen JP. Efficacy of once-daily indacaterol 75 µg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis. BMC Pulmonary Medicine 2012;12:29.
46. Donegan S, Williamson P, D'Alessandro U, Garner P, Tudur Smith C. Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials. Statistics in Medicine 2013;32(6):914-930.
47. Horsley T, Dingwall O, Sampson M. Checking reference lists to find additional studies for systematic reviews. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.MR000026.pub2; PUBMED: 21833989]
48. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regressionwith individual patient data meta-analysis. Journal of Clinical Epidemiology 2002;55:86–94.
49. Mathew T, Nordström K. On the equivalence of meta-analysis using literature and using individual patient data. Biometrics 1999;55(4):1221-3.
50. Mukhtar MA. Incorporation of heterogeneity in meta-analysis of randomised controlled trials. PhD Thesis 2008.
51. Olkin I, Sampson A. Comparison of meta-analysis versus analysis of variance of individual patient data. Biometrics 1998;54:317-22.
52. Steinberg KK, Smith SJ, Stroup DF, Olkin I, Lee NC, Williamson GD, et al. Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies. American Journal of Epidemiology 1997;145:917-25.
53. Clarke M, Stewart L, Tierney J, Williamson P. Individual patient data meta-analyses compared with meta-analyses based on aggregate data. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.MR000007]
54. Clarke MJ, Stewart L, Tierney J, Williamson PR. Individual patient data meta-analyses compared with meta-analyses based on aggregate data. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.MR000007.pub2]